| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2017NatCo...8.1459W |
| P6179 | Dimensions Publication ID | 1092580956 |
| P356 | DOI | 10.1038/S41467-017-01669-Z |
| P932 | PMC publication ID | 5682281 |
| P698 | PubMed publication ID | 29129917 |
| P50 | author | Kenneth Kim | Q65555409 |
| Annie Elong Ngono | Q66717841 | ||
| Jose Angel Regla-Nava | Q66729725 | ||
| Jinsheng Wen | Q66751057 | ||
| Matthew J. Gorman | Q110877848 | ||
| Michael S. Diamond | Q28051146 | ||
| Sujan Shresta | Q28743766 | ||
| P2860 | cites work | Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014 | Q22330724 |
| Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice | Q39279894 | ||
| Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells | Q39434858 | ||
| Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections | Q40047603 | ||
| Zika Virus Transmission - Region of the Americas, May 15, 2015-December 15, 2016. | Q40048208 | ||
| A Mouse Model of Zika Virus Sexual Transmission and Vaginal Viral Replication | Q40051279 | ||
| HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses | Q40095654 | ||
| Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes | Q40502077 | ||
| Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever | Q40631748 | ||
| Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications | Q22330725 | ||
| Current Zika virus epidemiology and recent epidemics | Q22330739 | ||
| Zika Virus and Birth Defects — Reviewing the Evidence for Causality | Q23815222 | ||
| A Mouse Model of Zika Virus Pathogenesis | Q24261408 | ||
| Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus | Q24737245 | ||
| Structural basis of potent Zika–dengue virus antibody cross-neutralization | Q24740325 | ||
| Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus | Q25161212 | ||
| Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro | Q25708158 | ||
| Brazil asks whether Zika acts alone to cause birth defects | Q26247220 | ||
| Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus | Q26247258 | ||
| Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection | Q26252507 | ||
| Zika-induced antibody response enhances dengue serotype 2 replication in vitro | Q26262372 | ||
| An Ecological Assessment of the Pandemic Threat of Zika Virus | Q26706937 | ||
| Dengue Antibody and Zika: Friend or Foe? | Q26810984 | ||
| Can non-human primates serve as models for investigating dengue disease pathogenesis? | Q26825708 | ||
| Dengue viruses - an overview | Q27026302 | ||
| Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia | Q27107337 | ||
| Illustrating and homology modeling the proteins of the Zika virus | Q27313484 | ||
| Differential Functional Avidity of Dengue Virus-Specific T-Cell Clones for Variant Peptides Representing Heterologous and Previously Encountered Serotypes | Q27481452 | ||
| Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization | Q27484661 | ||
| The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection | Q27488224 | ||
| Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection | Q27488337 | ||
| A Protective Role for Dengue Virus-Specific CD8+ T Cells | Q27488347 | ||
| Neutralization mechanism of a highly potent antibody against Zika virus | Q27924235 | ||
| Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection | Q28108975 | ||
| Zika Virus Infection in the Central Nervous System and Female Genital Tract | Q28119495 | ||
| Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice | Q28223043 | ||
| Dengue virus antibodies enhance Zika virus infection | Q28353949 | ||
| Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells | Q28950660 | ||
| Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity | Q29196526 | ||
| Research on dengue during World War II | Q29619423 | ||
| Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak | Q29619424 | ||
| Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever | Q29619585 | ||
| Dengue | Q29619772 | ||
| Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies | Q30145645 | ||
| CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus | Q30394327 | ||
| Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand | Q31032937 | ||
| Zika Virus Infection Associated With Severe Thrombocytopenia | Q33433912 | ||
| Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus | Q33850577 | ||
| Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue | Q34207386 | ||
| CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination | Q34234563 | ||
| CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice | Q34289194 | ||
| Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease | Q34487028 | ||
| Review article: Research on dengue during World War II revisited | Q34640272 | ||
| Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design | Q35268996 | ||
| Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity | Q35701686 | ||
| CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice | Q35760439 | ||
| Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype | Q35935142 | ||
| Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells | Q36895622 | ||
| Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity | Q37062703 | ||
| Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a | Q37360615 | ||
| A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand | Q37443026 | ||
| Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection | Q37604714 | ||
| The pathogenesis of dengue | Q37904027 | ||
| The human antibody response to dengue virus infection | Q37987124 | ||
| Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques | Q38157106 | ||
| Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models | Q38498172 | ||
| New insights into the immunopathology and control of dengue virus infection | Q38646923 | ||
| Epidemiologic studies on Dengue in Santiago de Cuba, 1997. | Q39038290 | ||
| Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. | Q39185722 | ||
| T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? | Q39263024 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Dengue virus | Q476209 |
| Zika virus | Q202864 | ||
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P304 | page(s) | 1459 | |
| P577 | publication date | 2017-11-13 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge | |
| P478 | volume | 8 |
| Q56337689 | Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge |
| Q63246493 | Anti-CD8 monoclonal antibody-mediated depletion alters the phenotype and behavior of surviving CD8+ T cells |
| Q62485190 | Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine? |
| Q61053646 | CD4+ T cells promote humoral immunity and viral control during Zika virus infection |
| Q92908363 | Climate drives spatial variation in Zika epidemics in Latin America |
| Q90050778 | Co-circulation of dengue, chikungunya, and Zika viruses and cross-protection |
| Q60031600 | Concomitant transmission of dengue, chikungunya and Zika viruses in Brazil: Clinical and epidemiological findings from surveillance for acute febrile illness |
| Q64257362 | Cross-Protection Against Four Serotypes of Dengue Virus in Mice Conferred by a Zika DNA Vaccine |
| Q90345244 | Cross-Reactive Immunity Among Flaviviruses |
| Q66679685 | Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development |
| Q57486493 | Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus |
| Q56341981 | Cross-reactive Dengue virus-specific CD8 T cells protect against Zika virus during pregnancy |
| Q58566107 | Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8 T Cells |
| Q91711499 | Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade |
| Q61795493 | Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy |
| Q99726129 | Dengue and Zika Viruses: Epidemiological History, Potential Therapies, and Promising Vaccines |
| Q92939082 | Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model |
| Q47551875 | Development of Zika Virus Vaccines |
| Q99711556 | Effector CD8 T Cell-Dependent Zika Virus Control in the CNS: A Matter of Time and Numbers |
| Q91566784 | Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses |
| Q66679208 | Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice |
| Q47558165 | Human T-cell immunity against the emerging and re-emerging viruses. |
| Q62485287 | Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates |
| Q66679116 | Identification of Protective CD8 T Cell Responses in a Mouse Model of Zika Virus Infection |
| Q51336680 | Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development. |
| Q58426387 | Immune responses to dengue virus in the skin |
| Q66680070 | In-depth characterization of congenital Zika syndrome in immunocompetent mice: Antibody-dependent enhancement and an antiviral peptide therapy |
| Q63248437 | Late Neurological Consequences of Zika Virus Infection: Risk Factors and Pharmaceutical Approaches |
| Q91650081 | Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice |
| Q55084480 | Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice. |
| Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
| Q64259781 | Mouse Models of Heterologous Flavivirus Immunity: A Role for Cross-Reactive T Cells |
| Q57476548 | Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever |
| Q104135089 | Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63 |
| Q99731999 | Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response✰,✰✰ |
| Q66678770 | Primary infection with dengue or Zika virus does not affect the severity of heterologous secondary infection in macaques |
| Q61053658 | Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua |
| Q99731978 | Protective and enhancing interactions among dengue viruses 1-4 and Zika virus |
| Q92422171 | Protective to a T: The Role of T Cells during Zika Virus Infection |
| Q90055118 | Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants |
| Q63246534 | T-Cell Response to Viral Hemorrhagic Fevers |
| Q94522058 | The continued threat of emerging flaviviruses |
| Q51336389 | The immunology of Zika Virus. |
| Q90197061 | Time elapsed between Zika and dengue virus infections affects antibody and T cell responses |
| Q91741475 | Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design |
| Q66679277 | Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice |
| Q61795469 | Zika virus infection in Malaysia: an epidemiological, clinical and virological analysis |
Search more.